id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-330126-sny9w9y8	Deng, Fuxue	Corticosteroids in diabetes patients infected with COVID-19	2020-06-25		.txt	text/plain	1151	61	44	A large national analysis investigating the comorbidity and its effect on 1590 patients with COVID-19 from 575 hospitals around mainland China showed that diabetes (8.2%) is the second most prevalent comorbidity following hypertension (16.9%), and its hazard ratio (HR) is 1.59 with 95% confidence interval (CI) between 1.03 and 2.45 after adjusting for age and smoking status [1] . An analysis of medical history, symptoms and signs, demographic data, and laboratory and CT results from 174 consecutive patients with COVID-19 revealed that diabetes is a risk factor for COVID-19 and a poor prognostic predictor of the disease [2] . Therefore, patients with diabetes and prediabetes who were infected with COVID-19 are a huge population in China and need close attention and care in treatment. An Expert Consensus on the Use of Corticosteroid in Patients with 2019-nCoV Pneumonia in China mentioned the dispute and controversy about corticosteroid usage for patients with COVID-19 and suggested that glucocorticoids should be administered with caution.	./cache/cord-330126-sny9w9y8.txt	./txt/cord-330126-sny9w9y8.txt